VJDementia is committed to improving our service to you

Share this video  

VJDementia is committed to improving our service to you

AAIC 2020 | Advantages of biomarker blood tests for Alzheimer’s diagnosis

Suzanne Schindler, MD, PhD, Washington University in St. Louis School of Medicine, St. Louis, MO, explains how many patients may have memory impairment symptoms, but the cause is unknown. Thus, having a blood test would improve the diagnostic tools for dementia as it would be an option that is not as expensive as an amyloid PET scan or invasive as a spinal tap. This interview was recorded during an online conference with The Video Journal of Dementia (VJDementia).